3161 Hits
3161 Hits
WP IP
News and commentary on IP issues
3682 Hits
3682 Hits
3194 Hits
3194 Hits
2714 Hits
2714 Hits
3807 Hits
3807 Hits
4040 Hits
4040 Hits
3447 Hits
3447 Hits
4012 Hits
4012 Hits
3507 Hits
3507 Hits
As of 1 January 2021, a UK, Gibraltar or Channel Islands address for service will be required for any new UK IP rights. This change has received parliamentary approval and is implemented in a UK IPO notice (TPN 2/2020) dated 21 December 2020. Action should be taken and we would be very happy to assist. If your IP rights are&nbs...
4407 Hits
4407 Hits
We are delighted that the UK Court of Appeal has today granted Dr Thaler the right to appeal the DABUS decision, which involves the important issue of patentability of inventions created by AI systems. Williams Powell is handling the DABUS patent applications as well as the UK and EPO appeals. The cases had been rejected by the UK High Court. The o...
3596 Hits
3596 Hits
As of January 2021, parties will no longer have free choice on whether a hearing (oral proceedings) during examination or opposition is in person or via video conferencing before the European Patent Office (EPO). Video conferences will be the default. 12 months ago, we would have had to fight for a hearing (oral proceedings) to be held with t...
3607 Hits
3607 Hits
A Supplementary Protection Certificate (SPC) can provide up to five years additional protection for a patented active ingredient of a pharmaceutical product that has received a marketing authorisation. The objective is to compensate a patent holder for the delay in being able to use the patent by the need to obtain the marketing authorisation. An S...
2444 Hits
2444 Hits
We have previously written about our involvement in filing and prosecuting patent applications for two inventions created by the AI inventor DABUS, and naming DABUS (the true deviser of the inventions) as the inventor.The UK IPO found the inventions to be both novel and inventive, and therefore, in principle, protectable by patent. ...
2841 Hits
2841 Hits
On 20 July 2020, the UK Government announced its official withdrawal from the Unified Patent Court (UPC) Agreement. This is a disappointment but not unexpected. Does this mark an end to over 40 years of efforts to produce a harmonised IP litigation process in Europe? Of course not. The UPC has, in recent year...
3275 Hits
3275 Hits
Ever since the Decision issued back in 1997 in the case of Biogen v Medeva the concept of insufficiency has been extended, particularly in the chemical and biotech fields, to include claims that have "excessive breadth" (so-called "Biogen insufficiency"). The Courts in the UK have applied this frequently to revoke patents that they decide clai...
3460 Hits
3460 Hits
Regeneron Pharmaceuticals' European patent EP 1360287 and its divisional EP 2264163 relate to methods of producing transgenic mice able to produce antibodies having human sequences, and the mice produced thereby. These patents covered the idea of producing mice having mixed human-murine gene sequences that could be subsequently modified t...
3612 Hits
3612 Hits
The European patent office has announced here that until 31 August 2020, no surcharge is payable for late paid renewal fees. This provision applies to EPO renewal fees having a deadline (without extension) between 15 March 2020 and 30 August 2020. Cases falling into this provision, will be deemed validly paid if the renew...
2976 Hits
2976 Hits
3902 Hits
3902 Hits
The European Patent Office's Enlarged Board of Appeal, decided that "dynamic interpretation" on legal issues is possible and has issued a ruling that reverses its previous position and significantly changes the patentability of plants, plant materials and animals at the European Patent Office. The Enlarged Board of Appeal, ...
17104 Hits
17104 Hits
©
2007 - 2024
Williams Powell
All rights reserved.
Williams Powell are regulated by IPREG whose code of conduct can be found here.These pages aim to provide a source of information for both non-professional enquirers e.g. inventors and their companies in the U.K. and professional consultants and advisers throughout the rest of the world. The pages are not intended to provide legal advice, which will only be provided on direct application to us in the formal context of a client/attorney relationship.
The information provided is correct to the best of our knowledge and belief, but is provided without obligation or guarantee. It will be updated from time to time as needed.